Bristol Myers Squibb axes 79 more in New Jersey as $1.5B cost-reduction program rolls on kdunleavy Fri, 09/20/2024 – 14:02 More: Bristol Myers Squibb axes 79 more in New Jersey as .5B cost-reduction program rolls on Source: fierce
read moreAfter prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa fkansteiner Fri, 09/20/2024 – 13:44 More: After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa Source: fierce
read moreGilead taps Korea’s Yuhan to supply HIV drug ingredients in $81M deal zbecker Fri, 09/20/2024 – 10:41 More: Gilead taps Korea's Yuhan to supply HIV drug ingredients in M deal Source: fierce
read moreGilead’s Kite exits China cell therapy joint venture with Fosun Pharma aliu Thu, 09/19/2024 – 15:56 More: Gilead's Kite exits China cell therapy joint venture with Fosun Pharma Source: fierce
read moreNew migraine drugs less effective than previous generation of triptan meds: BMJ study kdunleavy Thu, 09/19/2024 – 11:08 More: New migraine drugs less effective than previous generation of triptan meds: BMJ study Source: fierce
read moreAscellaHealth launches podcast to address challenges in specialty pharma apark Thu, 09/19/2024 – 10:26 More: AscellaHealth launches podcast to address challenges in specialty pharma Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals